GlassScriptPhysician profile
Kimberly S Wolf
NPI 1285628610
$2,195.01
in general payments reported to CMS, 2019-2025
17 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $824 · 2022: $515 · 2023: $286 · 2024: $284 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $801.53 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $407.51 | 2021-2025 | Farxiga |
| Lilly USA, LLC | $278.17 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Biohaven Pharmaceuticals, INC. | $193.12 | 2021 | |
| Abbvie INC. | $103.24 | 2022-2025 | |
| Exact Sciences Corporation | $68.68 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $54.65 | 2024-2025 | Repatha, Otezla, Repatha |
| Corcept Therapeutics | $45.78 | 2025 | Korlym |
| Dexcom, INC. | $38.13 | 2024-2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $37.99 | 2023-2024 | Quviviq |
| Avvisto Therapeutics, LLC | $36.15 | 2024 | Cycloset |
| Janssen Pharmaceuticals, INC | $32.59 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.85 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.68 | 2022 | |
| Lundbeck LLC | $18.82 | 2025 | Vyepti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $18.70 | 2025 | Gvoke Hypopen |
| Eisai INC. | $16.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.